Plasma membrane, Surface antigen-like
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 55 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 24, no: 5 |
NetGPI | no | yes: 0, no: 29 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 30 |
GO:0042995 | cell projection | 2 | 30 |
GO:0043226 | organelle | 2 | 30 |
GO:0043227 | membrane-bounded organelle | 3 | 30 |
GO:0110165 | cellular anatomical entity | 1 | 30 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 30 |
GO:0016020 | membrane | 2 | 9 |
Related structures:
AlphaFold database: A0A3S7WPB2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 96 | 100 | PF00656 | 0.341 |
DOC_CDC14_PxL_1 | 43 | 51 | PF14671 | 0.334 |
DOC_MAPK_gen_1 | 126 | 135 | PF00069 | 0.397 |
DOC_MAPK_MEF2A_6 | 44 | 51 | PF00069 | 0.324 |
DOC_PP1_RVXF_1 | 130 | 136 | PF00149 | 0.349 |
DOC_USP7_MATH_1 | 192 | 196 | PF00917 | 0.448 |
DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.533 |
DOC_USP7_MATH_1 | 278 | 282 | PF00917 | 0.319 |
DOC_USP7_MATH_1 | 69 | 73 | PF00917 | 0.420 |
DOC_USP7_MATH_2 | 145 | 151 | PF00917 | 0.340 |
DOC_USP7_UBL2_3 | 40 | 44 | PF12436 | 0.359 |
LIG_14-3-3_CanoR_1 | 244 | 253 | PF00244 | 0.447 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.760 |
LIG_BRCT_BRCA1_1 | 155 | 159 | PF00533 | 0.421 |
LIG_BRCT_BRCA1_1 | 239 | 243 | PF00533 | 0.401 |
LIG_BRCT_BRCA1_1 | 280 | 284 | PF00533 | 0.299 |
LIG_BRCT_BRCA1_1 | 81 | 85 | PF00533 | 0.502 |
LIG_Clathr_ClatBox_1 | 154 | 158 | PF01394 | 0.425 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.477 |
LIG_FHA_1 | 26 | 32 | PF00498 | 0.446 |
LIG_FHA_1 | 267 | 273 | PF00498 | 0.366 |
LIG_FHA_1 | 68 | 74 | PF00498 | 0.451 |
LIG_FHA_1 | 9 | 15 | PF00498 | 0.536 |
LIG_FHA_2 | 129 | 135 | PF00498 | 0.500 |
LIG_FHA_2 | 88 | 94 | PF00498 | 0.442 |
LIG_LIR_Gen_1 | 123 | 130 | PF02991 | 0.379 |
LIG_LIR_Gen_1 | 195 | 204 | PF02991 | 0.436 |
LIG_LIR_Gen_1 | 35 | 46 | PF02991 | 0.464 |
LIG_LIR_Gen_1 | 4 | 14 | PF02991 | 0.519 |
LIG_LIR_Gen_1 | 82 | 92 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 123 | 127 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 160 | 166 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 195 | 200 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 4 | 9 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 82 | 88 | PF02991 | 0.462 |
LIG_PDZ_Class_2 | 279 | 284 | PF00595 | 0.509 |
LIG_Pex14_2 | 193 | 197 | PF04695 | 0.424 |
LIG_PTB_Apo_2 | 158 | 165 | PF02174 | 0.390 |
LIG_SH2_CRK | 166 | 170 | PF00017 | 0.324 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.434 |
LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.532 |
LIG_SH3_3 | 17 | 23 | PF00018 | 0.589 |
LIG_SH3_3 | 252 | 258 | PF00018 | 0.476 |
LIG_Sin3_3 | 15 | 22 | PF02671 | 0.483 |
LIG_SUMO_SIM_par_1 | 153 | 158 | PF11976 | 0.361 |
LIG_SUMO_SIM_par_1 | 275 | 281 | PF11976 | 0.381 |
MOD_CK1_1 | 125 | 131 | PF00069 | 0.396 |
MOD_CK1_1 | 150 | 156 | PF00069 | 0.405 |
MOD_CK1_1 | 195 | 201 | PF00069 | 0.409 |
MOD_CK1_1 | 220 | 226 | PF00069 | 0.426 |
MOD_CK1_1 | 245 | 251 | PF00069 | 0.476 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.571 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.533 |
MOD_CK2_1 | 87 | 93 | PF00069 | 0.468 |
MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.672 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.740 |
MOD_GlcNHglycan | 247 | 250 | PF01048 | 0.720 |
MOD_GlcNHglycan | 67 | 70 | PF01048 | 0.604 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.415 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.353 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.428 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.616 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.382 |
MOD_GSK3_1 | 245 | 252 | PF00069 | 0.454 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.502 |
MOD_GSK3_1 | 65 | 72 | PF00069 | 0.413 |
MOD_N-GLC_1 | 171 | 176 | PF02516 | 0.603 |
MOD_N-GLC_2 | 57 | 59 | PF02516 | 0.529 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.561 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.463 |
MOD_NEK2_1 | 116 | 121 | PF00069 | 0.509 |
MOD_NEK2_1 | 133 | 138 | PF00069 | 0.382 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.380 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.402 |
MOD_NEK2_1 | 206 | 211 | PF00069 | 0.388 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.732 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.430 |
MOD_PIKK_1 | 177 | 183 | PF00454 | 0.422 |
MOD_PIKK_1 | 32 | 38 | PF00454 | 0.441 |
MOD_PKA_2 | 114 | 120 | PF00069 | 0.440 |
MOD_PKA_2 | 125 | 131 | PF00069 | 0.359 |
MOD_PKA_2 | 138 | 144 | PF00069 | 0.379 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.349 |
MOD_Plk_1 | 94 | 100 | PF00069 | 0.337 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.470 |
MOD_Plk_4 | 159 | 165 | PF00069 | 0.462 |
MOD_Plk_4 | 278 | 284 | PF00069 | 0.350 |
MOD_SUMO_rev_2 | 219 | 225 | PF00179 | 0.387 |
TRG_ER_diArg_1 | 137 | 140 | PF00400 | 0.357 |
TRG_NES_CRM1_1 | 146 | 158 | PF08389 | 0.316 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2E6 | Leptomonas seymouri | 28% | 100% |
A0A0N0P2L4 | Leptomonas seymouri | 27% | 96% |
A0A0N0P4M2 | Leptomonas seymouri | 32% | 100% |
A0A0S4IVH1 | Bodo saltans | 28% | 100% |
A0A1X0NKN8 | Trypanosomatidae | 39% | 99% |
A0A3Q8I9A6 | Leishmania donovani | 23% | 100% |
A0A3Q8I9D0 | Leishmania donovani | 30% | 100% |
A0A3Q8IIJ9 | Leishmania donovani | 25% | 100% |
A0A3S5H6D6 | Leishmania donovani | 29% | 100% |
A0A3S7WP69 | Leishmania donovani | 33% | 100% |
A0A3S7X4J4 | Leishmania donovani | 25% | 94% |
A4H4D2 | Leishmania braziliensis | 29% | 100% |
A4H4G6 | Leishmania braziliensis | 80% | 100% |
A4H5P0 | Leishmania braziliensis | 30% | 100% |
A4HJC8 | Leishmania braziliensis | 21% | 100% |
A4HSL2 | Leishmania infantum | 33% | 100% |
A4HTX9 | Leishmania infantum | 28% | 100% |
A4HVB0 | Leishmania infantum | 24% | 70% |
A4I6S4 | Leishmania infantum | 25% | 100% |
E8NHP8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 94% |
E9ACQ0 | Leishmania major | 94% | 100% |
E9AG65 | Leishmania infantum | 100% | 100% |
E9AGG5 | Leishmania infantum | 24% | 68% |
E9AGH0 | Leishmania infantum | 26% | 100% |
E9AKJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% |
E9AKM8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
E9AMQ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9AP02 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
E9AP03 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9AP07 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9AP08 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 22% | 68% |
E9B1U4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 83% |
E9B1U5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 68% |
E9B1U6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 94% |
P58822 | Phaseolus vulgaris | 26% | 83% |
Q25331 | Leishmania major | 30% | 74% |
Q4Q6B6 | Leishmania major | 26% | 94% |
Q4Q6B7 | Leishmania major | 26% | 94% |
Q4QGJ4 | Leishmania major | 30% | 74% |
Q4QGJ7 | Leishmania major | 30% | 76% |
Q4QGK6 | Leishmania major | 30% | 74% |
Q4QGL4 | Leishmania major | 28% | 72% |
Q4QHW6 | Leishmania major | 29% | 100% |
Q4QJB2 | Leishmania major | 30% | 100% |